In silico Investigation of the Interactions of Thymol and Carvacrol on the Spike Protein of Omicron Variant and MPro Enzyme of Coronavirus
Öz
Anahtar Kelimeler
T. vulgaris, Thymol, Carvacrol, Severe acute respiratory syndrome coronavirus 2, Molecular Docking, ADMET
Kaynakça
- Alp, M & Alp, A.S. (2019). Medisinal Kimyaya Kısa Bir Giriş (1st ed.). Akademisyen Kitabevi.
- Amirghofran, Z., Ahmadi, H., Karimi, M. H. (2012). Immunomodulatory Activity of the Water Extract of Thymus vulgaris, Thymus daenensis, and Zataria multiflora on Dendritic Cells and T Cells Responses. Journal of Immunoassay and Immunochemistry, 33(4), 388–402. https://doi.org/10.1080/15321819.2012.655822.
- Banerjee, P., Eckert, A. O., Schrey, A. K., Preissner, R. (2018). ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Research, 46, W257–W263. https://doi.org/10.1093/nar/gky318.
- Bank, R. P. D. RCSB PDB - 7T9J: Cryo-EM structure of the SARS-CoV-2 Omicron spike protein. Retrieved July 25, 2022, from https://www.rcsb.org/structure/7T9J.
- BIOVIA, Dassault Systèmes, (2021). BIOVA Discovery Studio Visualizer 2021, v21.1.0.20298, San Diego: Dassault Systèmes,
- Catella, C., Camero, M., Lucente, M.S., Fracchiolla, G., Sblano, S., Tempesta, M., Martella, V., Buonavoglia, C., Lanave, G. (2021). Virucidal and antiviral effects of Thymus vulgaris essential oil on feline coronavirus, Research in Veterinary Science, 137, 44-47. https://doi.org/10.1016/j.rvsc.2021.04.024.
- Narkhede R. R., Cheke R. S., Ambhore J. P., Shinde S. D., (2020). The Molecular Docking Study of Potential Drug Candidates Showing Anti-COVID-19 Activity by Exploring of Therapeutic Targets of SARS-CoV-2. Eurasian Journal of Medicine and Oncology. 4(3), 185-195.| DOI: 10.14744/ejmo.2020.31503.
- Daina, A., Michielin, O., Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717.
- Daoud, S., Alabed, S. J., Dahabiyeh, L. A. (2021). Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies. Acta Pharmaceutica, 71(2), 163–174. https://doi.org/10.2478/acph-2021-0016.
- Fakhar, Z., Khan, S., AlOmar, S. Y., Alkhuriji, A., Ahmad, A. (2021). ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19. Scientific Reports, 11(1), 234. https://doi.org/10.1038/s41598-020-79918-3.